Argus Upgrades Equifax as Post-Earnings Positioning Firms Up

Equifax spent most of October as one of the more defensively positioned names in the data services peer group. That changed fast. The stock gained 16.8% over the past week, more than double the 6.5% median move for its closest peers, and Argus Research used Thursday's session to move the stock from Hold to Buy.

The Upgrade That Followed the Proof

Argus analyst John Eade cited the shift in Equifax's data business as the basis for the upgrade. The move comes after the October 20 earnings report triggered an 10.7% single-day gain, which the firm named explicitly in its rationale. Among closest peers, TransUnion also gained 17.9% over the week, suggesting sector tailwinds are real. Gartner rose 11.3% and Verisk added 6.5%, leaving Equifax at the front of the cohort but not uniquely so.

The analyst landscape remains split on targets even as the direction has shifted. BMO Capital's Ryan Griffin raised his target to $175 from $160 on October 21, maintaining Market Perform. Needham's Kyle Peterson went to $210 from $190, keeping Buy. Stifel's Shlomo Rosenbaum cut to $217 from $235, also maintaining Buy. The consensus target stands at $198.40 against Wednesday's close of $175.57, implying roughly 13% further upside.

Positioning Confirms the Shift

Short interest sits at 4.3% of the free float, down from roughly 7.4 million shares in early October to just over 5.3 million now. The drop happened before the earnings print, not after. Since results, SI has barely moved. The lending market reflects the same lack of conviction on the short side: availability remains exceptionally loose at 3,322%, meaning there are more than 33 shares available to borrow for every one currently lent out. There is no squeeze dynamic here.

The put/call ratio stood at 1.47 on October 21, against a 20-day mean of 1.93. That is nearly two standard deviations below the mean. Through most of October, the ratio ran above 2.0. The shift in options positioning preceded and then reinforced the earnings move.

Retail Attention Elevated

Wikipedia views and ORTEX stock page traffic for Equifax reached 2.7 standard deviations above the company's own 90-day average as of October 21. That reading, from the Wikipedia views dataset, reflects an unusual level of public interest following the earnings release. This is an attention measure, not a revenue indicator.

Equifax also repurchased $300 million of its own shares in Q2 2026, according to EDGAR XBRL buyback filings. That was up 135% on the same quarter last year and the largest Q2 buyback spend on record for the company since at least 2009.

What Changes the Picture

ORTEX puts the probability of Equifax joining the CRSP US Small index at 55% in the December 2026 quarterly review, which would require the stock to close above $180.88. A confirmed addition would bring an estimated $329 million of index-tracker buying, equivalent to 1.2 days of normal volume, with a trade date of December 22. The rank date is December 4 and announcement December 7. That price is 3% above current levels and is the level the index rule flips on, not a target.